News & Articles

Drop by SelectScience booth #205 at the SLAS2020 conference January 27-29

Commercial U.S. launch of this novel diagnostic tool to diagnose lower respiratory tract infections is expected in the first quarter of 2020

The latest research and new method downloads: multiplex assays, ELISA, proteomics, genomics, imaging and more

Co-directors of the ELRIG Research and Innovation 2020 meeting discuss current trends and challenges in protein biology and drug discovery

Watch this on-demand webinar to learn how real-time imaging can be used to track gene expression in live cancer cells

Discover the latest technologies and techniques that are revolutionizing immuno-oncology research

Adakveo targets key molecule for the prevention of sickle cell pathology

Thermo Fisher Scientific Orbitrap GC-MS technology to be integrated into Breath Biopsy to support identification of novel biomarkers for early disease detection

A mass spectrometry breath test, artificial intelligence algorithms and novel anti-inflammatory compounds among the innovations that could pave the way for better diagnoses and treatment

Watch this expert webinar to find out how real-time imaging is being used in cancer research to track gene expression

Discover how scientists at Medicine Discovery Catapult are using biomarkers to tailor approaches to patient care, in this exclusive interview with Dr. Sally Price

The diagnostic assay can be used to help diagnose patients with non-small cell lung cancer

I.W. Tremont CFP-DBS-v1 material for dried blood spot sampling, storage and transport delivers reliable performance for diagnostic applications

SelectScience is heading to Chicago, USA, to interview scientists at the forefront of neuroscience research and report on the latest techniques and technologies advancing the field

AMSBIO have introduced a new range of proprietary reagents designed for researchers investigating targeted cancer therapy.

New data show NfL may be a biomarker for predicting future disability outcomes

Study aims to develop a rapid point-of-care diagnostic based on multiple biomarkers to detect emergent sepsis

Abbott's new technology is poised to be the first point-of-care blood test for assessing concussions, providing doctors results in 15 minutes

Following last year’s success, we’re hosting our second annual event dedicated to celebrating our Seals of Quality program

Upgrades include launch of next-generation ReCIVA breath sampler and CASPER portable air supply

Akoya Biosciences determines that multiplex immunofluorescence technology preserves critical data missed by other biomarker strategies